Literature DB >> 6295542

High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.

K J Sheppard, D A Bradbury, J M Davies, D R Ryrie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6295542      PMCID： PMC1546636          DOI： 10.1136/bmj.286.6358.57

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Serum vitamin B12 and transcobalamin abnormalities in patients with cancer.

Authors:  R Carmel; L Eisenberg
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

2.  Negative interference by residual proteins in the supernatant fluid used in radioisotopic assay of serum vitamin B 12 .

Authors:  E Mortensen
Journal:  Clin Chem       Date:  1972-09       Impact factor: 8.327

3.  Radioisotope assay of vitamin B12 in human blood serum.

Authors:  W L Jacobs; H A Zondag
Journal:  Clin Chim Acta       Date:  1969-04       Impact factor: 3.786
  3 in total
  2 in total

1.  Fibrolamellar hepatocarcinoma: clinical, radiologic, and pathologic features.

Authors:  I R Francis; F P Agha; N W Thompson; D F Keren
Journal:  Gastrointest Radiol       Date:  1986

Review 2.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.